Phase II of AUY922 in Second-line Gastric Cancer in Combination With Trastuzumab in HER2 Positive Patients

NCT01402401 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Gastric Cancer

Interventions

DRUG: AUY922
DRUG: Trastuzumab

Sponsor

Novartis Pharmaceuticals